Healthy Clinical Trial
Official title:
The Assessment of Spot Reduction in Adults Males Following Endurance Training
NCT number | NCT05794854 |
Other study ID # | MUCSR12 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2005 |
Est. completion date | May 2006 |
Verified date | March 2023 |
Source | Molde University College |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Spot reduction, referring to local body fat reduction, pertains to subcutaneous adipose tissue utilization from specific body parts during exercise. Its existence has been keenly debated, although generally accepted not to occur during exercise. However, it is based on not only equivocal data - commonly the training protocol typically applied is based on strength rather than endurance training. The investigators sought to test this assumption by utilizing endurance based exercise controlling for energy expenditure and using dual x-ray absorptiometric measures to assess body composition before and after training.
Status | Completed |
Enrollment | 16 |
Est. completion date | May 2006 |
Est. primary completion date | May 2006 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 30 Years to 60 Years |
Eligibility | Inclusion Criteria: - males - = 30 years old - classified as overweight (Body mass index = 25 kg · m-2) - not participating in regular physical training Exclusion Criteria: - < 30 years old - Body mass index < 25 kg · m-2 - participating in regular physical training |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Molde University College | Norwegian University of Science and Technology |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Trunk lean mass change | Lean mass located in trunk (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Other | Lower extremity lean mass change | Lean mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Other | Upper extremity lean mass change | Lean mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Other | Total lean mass change | Total lean mass (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Other | Maximal oxygen uptake change | Maximal oxygen uptake by cardiopulmonary indirect calorimetry | Change from pre (baseline) to post test (after 10 weeks) | |
Other | Maximal muscle strength change | One-repetition maximum (kg) in torso rotation and abdominal crunch | Change from pre (baseline) to post test (after 10 weeks) | |
Primary | Trunk fat mass change | Fat mass located in trunk (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Secondary | Lower extremity fat mass change | Fat mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Secondary | Upper extremity fat mass change | Fat mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Secondary | Total fat mass change | Total fat mass (g) measured by dual-energy x-ray absorptiometry | Change from pre (baseline) to post test (after 10 weeks) | |
Secondary | Body weight change | Change from pre (baseline) to post test (after 10 weeks) | ||
Secondary | Body mass index change | Change from pre (baseline) to post test (after 10 weeks) | ||
Secondary | Waist circumference (cm) change | Change from pre (baseline) to post test (after 10 weeks) | ||
Secondary | Hip circumference (cm) change | Change from pre (baseline) to post test (after 10 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |